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1. Introduction 
Hearing loss (HL) is the most common sensory defect in human beings, affecting 1.86 in 
1000 newborns around the world which half of it is due to genetic causes (Morton & 
Nance, 2006). HL can be syndromic or nonsyndromic. Individuals affected with 
syndromic form have additional clinical signs whereas nonsyndromic HL is not 
associated with other clinical signs and symptoms.  All Mendelian pattern of inheritance 
have been observed in nonsyndromic HL (NSHL) including autosomal dominant (AD), 
autosomal recessive (AR), X-linked inheritance (XL) and mitochondrial inheritance (MT); 
autosomal recessive is the main form of NSHL, i.e. 75-85 % of NSHL show AR pattern in 
affected pedigrees. 
As known, ear is the organ of hearing and balance. Hearing is dependent on a series of 
complex events. The ear has three anatomical parts including outer, middle and inner ear. 
The external ear which is composed of the auricle, ear canal and eardrum membrane 
collects sound waves and transmits them to the eardrum. Three tiny bones of middle ear 
(the ossicles) act as levers and conduct the sounds to the oval window, and finally 
through the cochlea (a snail-shaped organ) which has the auditory receptors (the organ of 
Corti) in the inner ear [Raphael & Altschuler 2003].  A collagen-based extracellular matrix, 
called tectorial membrane on top of the hair cells is vibrated by sound waves [Richardson 
et al., 2008]. Within the organ of Corti, physical vibrations produce a mechanoelectrical 
transduction which is detected by hair cells and these cells respond by producing 
electrical impulses. Nerves transmit these impulses to the brain where they are 
interpreted.  Different sound frequencies stimulate the hair cells in different parts of the 
organ of Corti and lead to perception of different sound frequencies. Sounds are 
processed in both sides of the brain but the interpretation of the sounds takes place at the 
left side of brain.  Sounds are heard at normal hearing thresholds between 0-20 dB across 
the 125-8000 Hz range while loss of more than 20 dB, is said to have hearing loss which is 
confirmed by measuring pure tone average (PTA) (average hearing sensitivity at 500, 1000 
and 2000 Hz).  
Nearly one hundred and twenty million people suffer from hearing impairment around the 
world.  History of some important events about human hereditary HL is shown in table 1 
[Nance & Sweeney, 1975; Wallis et al., 1988; Kimberling et al., 1990; Leon et al., 1992; 
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Guilford et al., 1994; Kelsell et al., 1997; Lynch et al., 1997; Eudy et al., 1998; Gorlin, 2004; 
Dror & Avraham 2009].  
 
Time Event 
Sixteenth century Reports indicating the prevention of the deaf from marrying 
Seventeenth century The mode of recessive and dominant HL 
Nineteenth century “The most frequent causes of congenital deafness are hereditary.. .”  
1968 One of the genetic forms of deafness was described 
1975 The forms of HL, the need for research and genetic counseling were 
described 
1988 An X-linked form of deafness was mapped in a large Mauritian 
family 
1990 The first locus for syndromic HL, USH2A, was mapped 
1992 The first locus for ADNSHL*, DFNA1, was mapped in a Costa Rican 
family 
1994 The first and second loci for ARNSHL■, DFNB1 and DFNB2, and 
DFNA2 loci were mapped 
1997 GJB2 and DIAPH1 genes were discovered for DFNB1 and DFNA1 
loci, respectively 
*Autosomal domiant non syndromic hearing loss, ■Autosomal recessive nonsyndromic hearing loss 
Table 1. Chronological events regarding hereditary HL. 
One of the main programs of the World Health Organization (WHO) is to encourage 
countries for the prevention of deafness [Emery, 2003].  Understanding the molecular and 
genetic mechanisms of HL may lead to development of new therapy and treatment 
approaches. Here, we review major causes leading to either syndromic or nonsyndromic 
HL. 
2. Classification of hearing loss 
Approximately two-thirds of the HL affected children show the problem at birth and 
unfortunately it may not be diagnosed before the age of 3 years.  HL has several 
classification criteria which are important for diagnosis, prognosis and treatment [Mahdieh 
et al., 2010a].  These criteria are summarized in table 2. 
2.1 Etiology 
Based on the cause of sensorineural deafness, HL is categorized into three major forms as 
acquired, genetic and unknown.  There are many causes for hearing loss:  
1. Acquired HL: infectious and pharmaceutical agents known as teratogens would affect 
the sense of hearing.  HL could occur by physiological, biochemical or infectious factors. 
 However, genetic background has an important effect on its occurrence. The risk 
factors that may affect the hearing process are as follows:  
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a. factors before birth including congenital infections (e.g. toxoplasmosis, measles, 
syphilis, smallpox, cytomegalovirus, herpes virus), congenital deformities of aurical 
and ear duct [Willems, 2004; Shin et al., 2011]. 
b. factors during birth including prematurity and low birth weight (less than 1500gr) 
and increased blood bilirubin [Willems, 2004]. 
c. factors affecting after birth including infections and bacterial meningitis, mumps, 
otitis media, blood infection and autotxic drugs such as aminoglycosides, head 
injury or skull fracture which lead to anesthesia [Willems, 2004]. 
2. Genetic HL: the genetic basis of HL is known for more than 100 years. In the early 
decade of 1800s, the Irish physician William Wild explained the inheritance of HL.  His 
theory differentiated between dominant and recessive inheritance.  He also observed 
that men showed more X-linked transmission [Willems, 2004]. 
2.2 Severity 
Intensity of the sound is calculated in units of decibel (dB), which is logarithm intensity of 
the sound wave to a reference sound intensity divided by ten [Willems, 2004]. The normal 
hearing threshold is 15 dB. A regular conversation occurs at level of 45 to 60 dB. 
2.3 Position of damage 
a. Conductive HL: Factors affecting sound transmission including aurical, ear canal, 
eardrum, outer and middle ear bones to the cochlea cause conductive HL.  The most 
common causes of conductive HL are the external and middle ear congenital 
abnormalities such as atrophy and dysplasia, duct obstruction, impacted cerumen, 
otitis, middle ear and Tympanic membrane problems. 
b. Sensorineural HL (SNHL): The disorder occurs in the auditory nerve or the cochlea. In 
other words, the abnormalities occur some place between the hair cells and auditory 
brain regions. The most common causes of SNHL are:  
b1. congenital causes such as rubella, syphilis, Usher syndrome, Alport Syndrome, 
Waardenburg syndrome and autosomal dominant and recessive sensorineural 
deafness [Friedman et al., 2003]. 
b2. acquired factors: Infections such as measles, cytomegalovirus, bacterial meningitis,  
autotoxicity of drug consumption, noise pollution including long-term exposure, 
presbycusis and sudden idiopathic HL [Willems, 2004]. 
c. Mixed HL: in this type of hearing loss, conductive and sensorineural problems are 
observed simultaneously. Infections such as tuberculosis, some syndromes and skull 
fractures may also cause mixed HL. 
2.4 Age of onset 
On the basis of the age of onset, HL is divided into the following types:  
a. Prelingual: Loss of hearing occurs before speech is acquired. If a child has a congenital 
hearing impairment, he would not be able to speak normally.  
b. Postlingual: Loss of hearing occurs after speech is developed. 
c. Presbycusis or age-related HL (ARHL): Epidemiologic studies show that nearly 25 % of 
60 year olds and more than 50 % of 80 year ages undergo ARHL [Dror & Avraham, 
2009; Huang & Tang, 2010]. 
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2.5 Signs 
HL may be associated with other physical problems which are called syndromic HL.  
Genetic HLs without any other complications is called non-syndromic genetic hearing loss 
[Willems, 2004]. HL loci are named with the prefix DFN, followed by the mode of 
inheritance which is indicated by B, A, X and Y for autosomal recessive (DFNB), autosomal 
dominant (DFNA), X-linked (DFNX) and Y-linked (DFNY), respectively. The order in which 
loci have been described is denoted by a number after these letters, e.g. DFNB1 is the first 
identified locus causing autosomal recessive HL [Guilford et al., 1994]. 
 
Criterion Class Definition and example 
Age of onset Prelingual HL HL occurs before language acquisition 
Postlingual HL HL occurs after language acquisition 
Presbycusis Age-related HL 
Etiology 
 
Acquired Caused by environmental agents such as viral and 
bacterial infections (prenatal, e.g., CMV, toxoplasmosis, 
rubella; postnatal, e.g, meningitis), hyperbilirubinemia, 
head trauma, anoxia, noise exposure and ototoxic drugs 
Genetic Caused by gene mutation 
Idiopathic Unexplained cause 
Clinical 
phenotypes 
Syndromic associated with other symptoms 
Nonsyndromic Deafness is the only defect 
Position of 
damage 
Conductive HL Caused by a problem transferring sound waves through 
the external ear, tympanic membrane or middle ear 
Sensorineural HL Caused by damage to the inner ear (vestibulocochlear 
nerve) 
Mixed HL Caused by a combination of sensorineural and 
conductive HL 
Severity Mild  Difficulty in hearing of 26–40 dB sounds 
Moderate  41–55 dB 
Moderately severe 56–70 dB 
Severe  71–90 dB 
Profound  >90 dB 
Mode of 
inheritance 
Autosomal 
dominant 
DFNA loci (DFNA1-64) 
Autosomal 
recessive 
DFNB loci (DFNB1-96) 
Sex-linked DFNX loci (DFN1-8) 
Y-linked DFNY loci (DFNY1) 
Mitochondrial 12SrRNA (MT-RNR1), tRNASer(UCN) (MT-TS1) 
Table 2. Various criteria for the classification of hearing loss. 
3. The frequency of genetic HL 
Genetic HL occurs 1 in 2000 to 1 in 650 live births [Morton & Nance, 2006].  About 70% of 
the cases are nonsyndromic [Tekin et al., 2001].  Studies show that 75% of nonsyndromic HL 
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are inherited as autosomal recessive [Tekin et al., 2001].  10-20% of cases are inherited as 
autosomal dominant and 1-5% are X-linked recessive.  Approximately, 1% of human genes, 
i.e 200 to 250 genes are responsible for hereditary HL [Finsterer & Fellinger, 2005]. So far, 
more than one hundred loci and 55 genes have identified which are involved in 
nonsyndromic HL (http://hereditaryhearingloss.org). 
4. Non-syndromic HL 
A high frequency of genetic HL occurs without any abnormality in other organs classified as 
non-syndromic HL.  Different patterns of inheritance have been observed in NSHL. 
4.1 Different types of NSHL 
Variety of protein coding genes such as gap junctions (connexin encoding genes), motor 
proteins (myosins) cytoskeletal (e.g. actin), ion channels, structural proteins (Tectorin alpha, 
Otoancorin, Stereocilin, etc), transcription factors (POU3F4, POU4F3 and Eyes absent 4 or 
EYA4), and additionally microRNA genes are involved in HL [Willems, 2004; Mencia et al., 
2009; Mahdieh et al., 2010a]. GJB2 mutations are seen in 50% of autosomal recessive HL in 
the Caucasians [Kelsell et al., 1997; Tekin et al., 2001]. Some genes e.g. GJB2 gene is 
expressed in a variety of organs of the body while others such as OTOAncorin is only 
expressed in the inner ear. 
4.1.1 Autosomal recessive non-syndromic HL  
Autosomal recessive non-syndromic HL (ARNSHL) was first described in 1846.  It is the 
severest form of congenital HL in which there is a defect in cochlea in nearly all cases.  
Loci of ARNSHL are designated as the DFNB; DF stands for Deafness and B indicates the 
autosomal recessive pattern of inheritance. Up to date, 46 genes and nearly 100 loci have 
been identified for HL (Table 3). Regarding different studies, connexin 26 gene mutations 
differ depending on geographical place and ethnicity [Zelante et al., 1997; Morell et al., 
1998; Mahdieh & Rabbani, 2009]. Here, we discuss the most common genes causing 
ARNSHL.   
4.1.1.1 GJB2 and GJB6 genes and connexins 
The first locus of ARNSHL designated as DFNB1 was identified by Guilford and colleagues 
in 1994. These researches confirmed linkage to chromosome 13q12-q13 in two 
consanguineous families [Guilford et al., 1994].  More consanguineous families of different 
ethnic groups were linked to the DFNB1 locus [Morle et al., 2000].  Phenotypic differences 
were observed within different families which indicated that allelic heterogeneity may be 
present in the locus DFNB1.  
GJB2 is a small gene encompassing 5.5 Kb.  It has two exons encoding a 4.2Kb mRNA and a 
protein of 226 amino acids.  A six repeat of G is located at position 30 to 35 of coding region 
of GJB2 gene from which deletion of one G is known as 35delG or 30delG (Figure 1) [Kelley 
et al., 1998].  35delG is the most common mutation in the Caucasians and may cause up to 
70% of all GJB2 gene mutations. Profound HL caused by GJB2 gene mutations is found in 
50% of the cases; 30% are severe, 20% moderate and 1-2% are mild cases [Smith & Hone, 
2003].  Other GJB2 mutations have been reported with higher frequencies in some ethnic 
www.intechopen.com
 
Hearing Loss 
 
216 
groups [Morell et al., 1998; Mahdieh & Rabbani, 2009]. A large number of studies have been 
reported about GJB2 mutations including genotype-phenotype correlations, phenotypic 
variability, de novo mutations, dominant mutations, ethnic-specific distribution of 
mutations, digenic inheritance and allelic heterogeneity [del Castillo et al., 2002; Smith & 
Hone, 2003; Mahdieh et al., 2009; 2010b, 2010c].  Also, a modifier gene has been suggested 
because of intrafamilial phenotypic variability of the cases [Higert et al., 2009a; Mahdieh et 
al., 2010b].  
GJB2 and GJB6 genes are about 35 kb apart from each other.  GJB6 gene encodes a protein 
called Connexin 30 (MIM 604418) which has 261 amino acids.  Connexin 30 is produced in 
different tissues of the body such as the cochlea, brain and thyroid [Grifa et al., 1999]. The 
importance of this gene was evident when some families had a mutated allele of GJB2 and 
the second mutant allele was in the GJB6 (digenic inheritance) [del Castillo et al., 2002]. 
 
Locus Location Gene references 
X-Linked 
DFNX1 Xq22  PRPS1  Liu et al., 2010   
DFNX2  Xq21.1  POU3F4  De Kok et al., 1995   
DFNX4 Xp22  SMPX  del Castillo et al., 1996   
Autosomal Dominant 
DFNA1 5q31 DIAPH1 Lynch et al., 1997 
DFNA2A  1p34  KCNQ4 Kubisch et al., 1999  
DFNA2B  1p35.1 GJB3  Xia et al., 1998  
DFNA3A  13q11-q12  GJB2  Kelsell et al., 1997  
DFNA3B  13q12 GJB6 Grifa et al., 1999  
DFNA4  19q13  MYH14 Donaudy et al, 2004 
DFNA5  7p15  DFNA5 Van Laer et al., 1998  
DFNA6  4p16.3  WFS1 Bespalova et al., 2001  
DFNA9  14q12-q13  COCH Robertson et al., 1998  
DFNA10  6q22-q23  EYA4 Wayne et al., 2001  
DFNA11  11q12.3-q21  MYO7A Liu et al., 1997  
DFNA12  11q22-24  TECTA Verhoeven et al., 1998  
DFNA13  6p21  COL11A2 McGuirt et al., 1999  
DFNA15  5q31  POU4F3 Vahava et al., 1998  
DFNA17  22q  MYH9 Lalwani et al., 2000   
DFNA20  17q25  ACTG1 Zhu et al., 2003,  
DFNA22  6q13  MYO6 Melchionda et al.,  
DFNA28  8q22  GRHL2  Peters et al., 2002   
DFNA36  9q13-q21  TMC1 Kurima et al., 2002  
DFNA39  4q21.3  DSPP Xiao et al., 2001   
DFNA44  3q28-29  CCDC50  Modamio-Hoybjor et al., 2007   
DFNA48  12q13-q14  MYO1A Donaudy et al., 2003   
DFNA50  7q32.2  MIR96 Mencia et al., 2009 
DFNA51  9q21  TJP2 Walsh et al., 2010   
DFNA64 12q24.31-12q24.32 SMAC/DIABLO  Cheng et al., 2011   
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Locus Location Gene references 
Autosomal Recessive 
DFNB1  13q12  GJB2 Kelsell et al., 1997  
DFNB2  11q13.5  MYO7A Liu et al., 1997  
DFNB3  17p11.2  MYO15A  Wang et al., 1998  
DFNB4  7q31  SLC26A4  Li et al., 1998  
DFNB6  3p14-p21  TMIE Naz et al, 2002  
DFNB7/11  9q13-q21  TMC1 Kurima et al., 2002  
DFNB8/10  21q22  TMPRSS3  Scott et al., 2001  
DFNB9  2p22-p23  OTOF Yasunaga et al., 1999  
DFNB12  10q21-q22  CDH23 Bork et al., 2001  
DFNB15  19p13  GIPC3    Charizopoulou et al., 2011  
DFNB16  15q21-q22  STRC Verpy et al., 2001  
DFNB18  11p14-15.1  USH1C  Ouyang et al., 2002 
DFNB21  11q  TECTA Mustapha et al., 1999  
DFNB22  16p12.2  OTOA Zwaenepoel et al ., 2002  
DFNB23  10p11.2-q21  PCDH15 Ahmed et al, 2003  
DFNB24  11q23  RDX Khan et al., 2007  
DFNB25  4p13  GRXCR1    Schraders et al., 2010    
DFNB28  22q13  TRIOBP Riazuddin et al, 2006  
DFNB29  21q22  CLDN14 Wilcox et al., 2001  
DFNB30  10p11.1  MYO3A Walsh et al., 2002  
DFNB31  9q32-q34  WHRN Mburu et al., 2003  
DFNB32  1p13.3-22.1  GPSM2 Walsh et al., 2010  
DFNB35  14q24.1-24.3  ESRRB Collin et al., 2008  
DFNB36  1p36.3  ESPN Naz et al., 2004  
DFNB37  6q13  MYO6 Ahmed et al., 2003  
DFNB39  7q21.1  HGF Schultz et al., 2009  
DFNB42  3q13.31-q22.3  ILDR1   Borck et al., 2011   
DFNB49  5q12.3-q14.1.  MARVELD2 Riazuddin et al., 2006  
DFNB53  6p21.3  COL11A2 Chen et al., 2005  
DFNB59  2q31.1-q31.3  PJVK Delmaghani et al., 2006  
DFNB61  7q22.1  SLC26A5 Liu et al., 2003  
DFNB63  11q13.2-q13.4  LRTOMT/ COMT2 Ahmed et al., 2008   
DFNB66  6p21.2-22.3  LHFPL5 Shabbir et al., 2006 
DFNB72  19p13.3  GIPC3    Rehman et al., 2011  
DFNB73  1p32.3  BSND   Riazuddin et al., 2009   
DFNB74  12q14.2-q15  MSRB3   Ahmed et al., 2011 
DFNB77  18q12-q21  LOXHD1   Grillet et al., 2009  
DFNB79  9q34.3  TPRN Rehman et al., 2010   
DFNB84  12q21.2  PTPRQ Schraders er al., 2010  
DFNB91  6p25 SERPINB6 Sirmaci et al., 2010  
DFNB95  19p13  GIPC3    Charizopoulou et al., 2011   
Table 3. Non-syndromic genes responsible for HL up to 2011. 
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Fig. 1. Schematic structure and domains of Connexin 26 protein, Connexon and Gap 
Junction channel. A) The most common mutations in specific populations (35delG, 167delT, 
235delC, R143W and W24X mutations in the Caucasian, Ashkenazi Jewish, Japanese, 
Ghanian and Indian populations, respectively) are shown. 35delG, W24X, 167delT, 235delC 
and R143W located on NT, TM1, EC1, TM2 and TM3 domains, respectively. TM1-TM4 
denotes transmembrane domains, EC1-2 denotes extracellular domains, IC denotes 
cytoplasmic domain, NT denotes amino (NH2) terminus and CT denotes carboxyl (COOH) 
terminus. B) Six connexins can oligomerize to form hemichannels named connexons.  
Connexons then pass throughout the membrane to make the gap junction channels. 
Homomeric and heteromeric channels can be formed as connexins selectively interact with 
each other. 
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A few point mutations have also been reported in GJB6 as the cause of ARNSHL  GJB6 [del 
Castillo et al., 2005; Pallares-Ruiz et al., 2002].  Later studies determined that GJB6 mutations 
in cis state, not in trans, would destroy the GJB2 expression.  Therefore, the digenic 
hypothesis may not be correct.   Four large deletions have been recognized in GJB6 gene 
including del(GJB6-D13S1830), del(GJB6-D13S1854), del(chr13:19,837,344-19, 968,698) and 
920 Kb deletion [del Castillo et al., 2002, 2005; Wilch et al., 2010].  The deletions may include 
more than 10% of DFNB1alleles [Stevenson et al., 2003]. So far, del (GJB6-D13S1830) has not 
been seen in many populations [Mahdieh et al., 2004, 2011]. The del (GJB6-D13S1830) and 
del (GJB6-D13S1854) mutations not only truncate the synthesis of GJB6 gene but also destroy 
GJB2 gene expression.  
Connexins encoded by GJ genes are members of transmembrane family proteins that have 
20 members in humans [Holms & Steel, 1999].  These proteins were classified in three 
groups of alpha, beta and gamma proteins.  Common nomenclature system is based on 
molecular weight of proteins e.g. Cx26 and Cx32.  Despite the differences in the size and 
primary amino acid composition, connexins have similar topology.  These proteins have 
four transmembrane domains which are connected by two extracellular and one 
intracellular loop.  The carboxyl and amino terminals are located at the cytoplasmic side.  
Most cells express more than one type of connexin.  Gap junctions show different 
permeability and conductance which may create channels with specific characteristics.  
Also, in order to compensate for the decrease in the expression of some of the connexins, 
other connexins may be produced at an enhanced rate [Kumar & Kilula, 1996].  Hemi-
channels (connexons) are composed of six connexin subunits and two hemi-channels make 
the channel forming the gap junctions [Kelley et al., 1998].  The important role of these 
channels is transportation of potassium ions [Kelley et al., 1998] and glutamate released 
from hair cells to initiate action potential. Different connexins may be made up of hemi 
channels with homomer or heteromer subunits. 
4.1.1.2 MYO15A gene in DFNB3 locus 
In 1995, a report showed that 2% of rural individuals in the north coast of Bali, Indonesia 
were affected with a profound sensorineural non-syndromic HL.  Due to high percentage of 
deaf people in this village a local sign language had been created for communication [Wang 
et al., 1998].   
The locus was mapped on chromosome 17p11.2 by whole genome study.  MYO15A gene 
has 66 exons and 71097 bp, encoding a 11863 bp transcript [Liang et al., 1999].  Myosin gene 
was identified by positional and functional cloning approaches [Wang et al., 1998]. 
Mutations in the gene are responsible for 5% of severe to profound deafness cases in 
Pakistan [Friedman et al., 2003].  MYO15A gene mutations were reported in families from 
Turkey, Brazil and India [Kalay et al., 2007; Nal et al., 2007; Lezirovitz et al., 2008]. The role 
of myosin filaments can be traced in a variety of cellular functions including cell motility, 
muscle contraction, synaptic transmission, cytokenesis, endocytosis, exocytosis and 
probably in gene expression as a modulator [Craig & Woodhead, 2006; Loikkanen et al., 
2009]. As the organism gets more complex, there may be more myosin isoforms found in the 
organism [Oliver et al., 1999; Friedman et al., 1999].  The heavy chain of XV myosin has 3531 
amino acids.  There is a unique proline-rich region at the amino terminal of myosin which 
weighs 140KDa and has no similarity to any of the known proteins.  Next to this domain 
exists a motor domain and a tail domain [Belyantseva et al., 2003].  In addition to the 
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sensory cells of cochlear, myosin is expressed in the pituitary gland, neuroendocrine cells, 
parathyroid and pancreas [Llyod et al., 2001].  It is also found in stereocilia of hair cells 
[Belyantseva et al., 2003]. 
4.1.1.3 SLC26A4 gene in DFNB4 locus 
DFNB4 locus, located at chromosome 7q31, was first reported to be linked to recessive non-
syndromic deafness in a large Middle-Eastern Druze family. In 1997, the SLC26A4 (Penderin 
coding protein) was identified by positional cloning at the pendred syndrome locus (Everett 
et al. 1997) and was later also shown to be the gene mutated in DFNB4 [Li et al., 
1998]. Pendred syndrome was identified in 1896 as neurosensory HL and goiter.  HL in 
Pendred syndrome is the most common cause of deafness due to defect of cochlea such as 
dilation sac and duct of endolyph and enlarged vestibular duct [Everett et al., 1997]. 
Mutations of SLC26A4 gene are the second leading cause of ARNSHL.  So far, more than 140 
mutations have been reported for Pendred syndrome.  Phenotypic spectrum of SLC26A4 
gene mutations varies from Pendred syndrome to nonsyndromic HL.  Four mutations are 
common in northern Europeans i.e L236P, T416P, E384G, IVS8 +1 G> A) [Hilgert et al., 
2008].   In a study conducted in Spanish population 27% had homozygous SLC26A4 
mutations [Pera et al., 2008].  Mutations of SLC26A4 gene have been observed in several 
ethnic populations [Albert et al., 2006; Hu et al., 2007; Yoon et al., 2008]. The prevalence of 
SLC26A4 gene mutation is about 40% in Caucasians of which 24% are bi-allelic [Albert et al., 
2006]. 
SLC26A4 gene has 21 exons within 57175 bp of DNA sequence.  Its transcript is about 5 Kb 
encoding into a 87KDa protein having 780 amino acids.  The gene is expressed in lining cells 
of endolymph duct as well as non-sensory cells of utricle, saccule, kidney and thyroid. 
 Various models have been reported for the structure of Pendrin protein.  New model 
suggests that pendrin protein is a transmembrane protein traversing fifteen times 
throughout the membrane [Dossena et al., 2009].  The protein in involved in anion exchange 
of HCO-, Cl-, I-and OH- ions [Mount & Romero, 2004].  
4.1.1.4 TMC1 gene in DFNB7/11 locus 
DFNB7 and DFNB11 were determined as the cause of HL on chromosome 9q13-q21 in two 
Indian and two inbred Israeli families, respectively [Jian et al., 1995].  In 2002, eight different 
mutations in TMC1 gene were linked to one DFNA36 family and eleven DFNB7/11 families 
[Kurima et al., 2002].  More than twenty different point mutations and two deletions have 
been identified in different families.  It seems that c.100C>T mutation includes 
appromximately 40% of all TMC1 mutations in Turkey [Hilgert et al., 2008, 2009b].  In a 
survey of 51 Turkish families, 5 patients had mutations of TMC1 gene [Hilgert et al., 2008].  
Mutations of TMC1 are responsible for at least 6% of all cases of ARNSHL in northeast and 
eastern part of Turkey [Kalay et al., 2005].  Three mutations c.100C> T (R34X), c.77611G> A 
and g.94615A> C have been reported in Iranian families [Hilgert et al., 2009b].  
Based on sequence homology studies, eight TMC genes exist in vertebrates. TMC1 gene has 
24 exons and encodes a 3201 nucleotide RNA.  It expresses a complete transmembrane 
protein with six membrane passing domain which has no similarity to proteins of known 
function.  Mouse ortholog transcript (TMC1) is expressed in cochlea and vestibular hair cells 
[Kurima et al., 2002].   
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4.1.1.5 TMPRSS3 gene in DFNB8/10 locus 
DFNB8/10 locus was separately mapped on chromosome 21q22.3 in two consanguineous 
Pakistani (DFNB8) and Palestinian families (DFNB10) [Bonné-Tamir et al., 1996; Veske et al., 
1996].  Haplotype analysis and sequencing analysis of the families resulted in detection of 
mutations in TMPRSS3 [Scott et al., 2001]. The gene belongs to a subfamily of trans-
membrane serine proteases type III protein [Szabo et al., 2003] expressed in supporting cells 
of the organ of Corti [Guipponi et al., 2002].  Although, the specific role of TMPRSS3 protein 
in growth, development and survival of auditory apparatus has not been found but it 
activates the epithelial sodium channel (ENaC) in vitro [Guipponi et al., 2002]. The mutated 
alleles of the gene may inactivate the serine protease catalytic activitiy.  Therefore, TMPRSS3 
proteolytic function may be important during the development of inner ear [Guipponi et al., 
2002, 2008].   
TMPRSS3 gene has 13 exons within 24 Kb, encoding a 2468 bp mRNA which 
encodes a protein with 454 amino acids [Guipponi et al., 2008]. In 2009, 16 mutations in 
TMPRSS3 have been reviwed and reported by a study [Hilgert et al., 2009b].  From 
25 studied Turkish families, three had mutations of TMPRSS3 gene [Wattenhofer et al., 2005; 
Sahin-Calapoglu et al., 2005].  Mutations of TMPRSS3 gene account for 1% of hearing loss in 
Caucasian children with non-syndromic HL [Wattenhofer et al., 2005].  Mutations of 
TMPRSS3 gene have been reported in 4 of 290 Pakistani families [Ahmed et al., 2004]. 
4.1.1.6 OTOF gene in DFNB9 locus 
OTOF gene contains 48 exons encoding a 1997 amino acid polypeptide called otoferlin   
which is member of Ferlin family of proteins [Mirghomizadeh et al., 2002].  Ferlin family of 
proteins have a domain called C2.  These proteins contain a transmembrane C-terminal 
domain [Yasunaga et al., 1999].  C2 domain is a structural domain in some proteins that are 
involved in directing proteins to the cell membrane [Davletov & Südhof, 1993].  
Otoferlin is expressed in the brain and cochlea.  This protein plays an important role in 
releasing neurotransmitters in the auditory nerve cells [Yasunaga et al., 1999].  Mutations of 
the gene can lead to auditory neuropathy in which the sound from inner ear is not 
transferred to the brain.  Q829X mutation is very common in the Hispanic which is the third 
cause of ARNSHL [Migliosi et al., 2002].  Mutations of the gene have been found in families 
of Lebanese origin [Yasunaga et al., 1999].  Varga et al. reported 8 mutations in 65 studied 
families with ARNSHL [Varga et al., 2006]. OTOF mutations have been found in Pakistani 
families; gene mutations may account for deafness in 2.3% of this population [Choi et al., 
2009]. 
4.1.1.7 CDH23 gene in DFNB12 locus 
The superfamily of cadherin has about 100 members with a variety of roles in cell adhesion, 
growth and developmental signaling, maintenance and function of the tissues [Jamora & 
Fuchs, 2002; Nelson & Nusse, 2004; Gumbiner, 2005; Halbleib & Nelson, 2006].  Cadherin 23 
protein has a role in connection of developing stereocilia [Siemens et al., 2004].  
In 1996, DFNB12 was mapped to chromosome 10q21-q22 in a consanguineous Syrian family 
[Chaib et al., 1996]. Usher syndrome type 1 D (USH1D) was also mapped to the same 
position.  Allelic mutations of the CDH23 gene encoding cadherin 23 cause DFNB12 HL and 
USH1D [Bolz et al., 2001; Bork et al., 2001].  Missense mutations usually cause DFNB12 HL 
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but nonsense and premature stop codon mutations cause Usher syndrome type 1D although 
this relationship is not definite.  No single gene mutation is common in this gene [Hilgert 
2009b].  In 64 Japanese families, five mutations were found in CDH23 [Wagatsuma et al., 
2007]. 
4.1.1.8 TMHS or LHFPL5 genes in DFNB67 locus 
Non syndromic HL in a Pakistani family linked to a new region on chromosome 6p21.1-
p22.3 defining a new locus, DFNB67 in 2006; TMHS or LHFPL5 gene was mapped in this 
region [Shabbir et al., 2006].  LHFPL5 has 4 exons and encodes a 2162 nucleotide mRNA and 
translates into a protein of 219 amino acids. The proposed structure of the protein is a four 
pass transmembrane domain.  Mutations of this gene have been reported 
in patients from Pakistan and Turkey (C161F, Y127C, P83fsX84).  TMHS is important for the 
transmission of sound. 
4.1.2 Autosomal dominant non- syndromic hearing loss 
Late onset, mild and progressive forms of HL are the usual phenotypes associated with 
autosomal dominant form of deafness. About 25 genes and more than 60 loci have been 
reported for autosomal dominant non- syndromic hearing loss (ADNSHL).  There is no 
frequent gene mutated in ADNSHL but mutations in some genes including WFS1, KCNQ4, 
COCH and GJB2 have been suggested to be common (Kelsell et al., 1997; Nie 2008; Higert et 
al., 2009).  
4.1.2.1 WFS1 gene and its protein 
The WFS1 (Wolfram) gene at DFNA6 locus, located on 4p16, consists of 8 exons and has a 
length of about 33.4 kb and a 3.6 kb transcript. It codes for a polypeptide of 890 amino acids 
[Hofmann et al., 2003]. The Wolframin protein is a resident component of the endoplasmic 
reticulum (ER) and may be involved in membrane trafficking, processing and/or regulation 
of ER calcium homeostasis [Fonseca et al., 2010]. In the inner ear, however, this protein may 
be helpful to maintain the appropriate levels of calcium ions and/or other charged particles 
required for hearing process [Cryns et al., 2003].  
Dominant mutations in WFS1 can cause a characteristic type of HL which affects the low 
frequencies and less loss in hearing in the high frequencies [Bespalova et al., 2001; Fukuoka 
et al., 2007]. It has been shown that dominant mutations are usually located in the C-
terminal domain. The recessive Wolfram syndrome is caused by numerous mutations 
distributed along the entire gene. Two mutations c.424_425ins16 and c.1362_1377del16 have 
a high frequency in some specific populations including Spanish patients and Italians, 
respectively [Gómez-Zaera et al., 2001; Colosimo et al., 2003]. It is hypothesized that, 
inactivating mutations may lead to Wolfram syndrome and missense mutations occurring in 
the C-terminal domain can cause the characteristic low-frequency ADNSHL [Cryns et al., 
2003]. 
4.1.2.2 KCNQ4 gene and its protein 
The KCNQ4 gene at DFNA2 locus, located on 1p34, consists of 14 exons and codes for a 
polypeptide of 695 amino acids, a voltage-gated potassium channel. It is a member of the 
KCNQ voltage-gated K+ channel family [Coucke et al., 1999]. It has an important role in K+ 
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secretion into the endolymph by strial marginal cells. Ten missense mutations, two small 
deletions and one splice mutation in KCNQ4 have been reported so far. It is believed that a 
dominant-negative effect of the missense mutations in this gene lead to interference of the 
mutant protein with the normal channel subunit, affecting the pore structure of the 
channels. Therefore, hearing loss with a lower age of onset is observed at all frequencies 
[Coucke et al., 1999; Akita et al., 2001]. Deletion mutations which have a haploinsufficiency 
effect lead to a milder HL with an older age of onset at high frequencies [Coucke et al., 1999; 
Akita et al., 2001]. 
4.1.2.3 COCH gene and its protein 
The DFNA9 causative gene, COCH located on 14q12-q13, consists of 11exons and encodes a 
550 amino acid extracellular matrix protein named cochlin. This protein has several domains 
including two von Willebrand factor A-like domains (vWFA1 and 2) and a LCCL domain (a 
region homologous to a domain in factor C of Limulus). To date, eleven missense mutations 
and one small deletion in COCH gene have been reported. Most of the missense mutations 
are located within exon 4 and 5 which encode the LCCL domain (Figure 2) [Robertson et al., 
1998; Collin et al., 2006]. 
 
Fig. 2. Schematic structure of cochlin and distribution of the mutations along its domains. 
The NT signal peptide is followed by a LCCL domain and two vWF domains. S indicates 
several cysteine residues, NT denotes amino (NH2) terminus and CT denotes carboxyl 
(COOH) terminus.  
4.1.3 X and Y linked HL 
There are fewer X-linked forms of HL (DFNX) than ARNSHL and ADNSHL.  X-linked form 
of deafness has been reported as prelingual or progressive in different families.  Five loci 
and three genes (POU3F4, SMPX and PRPS1) have been reported for X-linked HL 
(http://hereditaryhearingloss.org/).   
To date, only one locus has been linked to chromosome Y (DFNY1) that was found in a very 
large Chinese family (seven generations) [Wang et al., 2004]. They reported that the ages of 
onset for the patrilineal relatives were from 7 to 27 years. PCDH11Y, encoding a 
protocadherin, was suggested to be the causality [Wang et al., 2004]. 
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4.1.4 Mitochondrial HL 
In healthy individuals, only one type of mitochondrial DNA genotype (homoplasmy) exists, 
but in many mitochondrial diseases, mitochondrial genome has mixed genotype 
(heteroplasmy).  Heteroplasmy differs from one tissue to another and can even differ within 
the cells of a tissue.  A few genes contribute to mitochondrial HL [Fischel-Ghodsian, 2003].   
Due to the important function of mitochondria in producing chemical energy through 
oxidative phosphorylation, mitochondrial DNA mutations can cause systemic 
neuromascular disorders such as HL.  mtDNA mutations may be inherited or acquired 
(Table 4); the inherited mitochondrial mutations can cause many clinical features including 
myopathy, neuropathy, diabetes mellitus and sensorineural HL [Finsterer & Fellinger, 2005; 
Guan 2011].   Acquired mitochondrial mutations may be associated with aging and age-
related HL or presbycusis [Fischel-Ghodsian, 1999, 2003].  Multiorganic mitochondrial 
syndromes are often lethal in homoplasmic state. Mitochondrial homoplasmy exists in 
LHON (Leber Hereditary Optic Neuropathy) and maternal inherited HL [Fischel-Ghodsian, 
2003]. Myoclonic epilepsy and ragged red fibers (MERRF), Kearns-Sayre syndrome (KSS) 
and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes are 
associated with progressive HL [Zeviani et al., 1998; Goto et al., 1990]. 
 
Reference  Phenotype  Mutation  Gene  
Estivill et al., 1998 NSHL/Aminoglycoside 
induced/worsened  
1555A->G  MTRNR1 (12S 
rRNA)  
  
  
Zhao et al., 2004  NSHL/Aminoglycoside 
induced/worsened  
1494C->T  
Bacino et al., 1995 NSHL/Aminoglycoside 
induced/worsened  
961 
(mutations) 
Zhao et al., 2004 NSHL/Aminoglycoside induced/ 
parkinsonism, and neuropathy 
1095T>C 
Li et al., 2005 NSHL/Aminoglycoside induced 827A>G 
Pandya et al., 1999;  NSHL/Aminoglycoside induced 7444G>A MTTS1 
(tRNASer(UCN))  Fischel-Ghodsian, 2003 NSHL/Palmoplantar keratoderma  7445A->G  
Jaksch et al., 1998 NSHL/Neurological dysfunction, 
including ataxia, dysarthria and 
myoclonus  
7472insC  
Hutchin et al.2000 NSHL/no additional symptoms  7510T->C  
Friedman et al., 1999  NSHL/no additional symptoms  7511T->C  
Jaksch et al., 1998 HL/Progressive myoclonic epilepsy 
and ataxia 
7512T>C 
Goto et al., 1990 maternally inherited diabetes and 
deafness/MELAS 
3243A>G MTTL1 
(tRNALeu(UUR)) 
Kameoka et al., 1998 maternally inherited diabetes and 
deafness 
8296A>G tRNALys 
Gal et al., 2010 dystonia, stroke-like episodes and HL8332A>G 
Rigoli et al., 2001 maternally inherited diabetes and 
deafness 
14709T>C tRNAGlu 
Table 4. Identified mitochondrial DNA mutations in HL. 
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5. Age-related HL 
Biological changes accumulate in people during life as individuals age. About one hundred 
thousand individuals die each day of age-related causes around the world [de Grey, 2007]. 
Age-related HL (ARHL) or presbycusis is the most frequent sensory defect in the elderly 
people. It occurs due to accumulation of environmental and genetic changes i.e. gradual 
deleterious changes in the ear gives rise hearing impairment in older people. Approximately 
25 % of 60 year olds and more than 50 % of 80 year ages suffer from ARHL [Dror & 
Avraham, 2009; Huang & Tang, 2010]. Many heterogeneous factors including family history, 
exposure to loud noises, ototoxic medication, exposure to chemicals, free radical (reactive 
oxygen species) chronic medical conditions, malnutrition, mtDNA mutations, alcohol abuse 
and smoking etc. may cause this type of HL [Van Eyken et al., 2007b; Huang & Tang, 2010]. 
Some common deletions and acquired mtDNA point mutations due to reactive oxygen 
spicies (ROS) have also been suggested to cause prebyscusis. Although genetic studies on 
ARHL are increasing in the recent years, there is a little information about the role of genes 
to its etiology. Two basic approaches have been used to identify susceptibility genes for 
ARHL: the linkage study and the association study [Van Eyken et al., 2007b]. Several single 
nucleotide polymorphisms (SNPs) have been reported to correlate with presbycusis; 
variants in GRHL2, GRM7, KCNQ4 and N-acetyltransferase 2 are involved (Table 5) [Van 
Eyken et al., 2006, 2007a; Van Laer et al., 2008; Friedman et al., 2009]. Mutations in cadherin 
23 coded by CDH23 gene may also cause ARHL [Johnson et al., 2010]. More recently, a 
genome-wide association scan was conducted on ARHL in the genetically isolated Finnish 
Saami population. This study confirmed, and also provided further evidence for the role of 
the previous reported gene, GRM7 in ARHL. IQGAP2 gene was also proposed to be 
involved in presbycusis [van Laer et al., 2010]. Mechanism of ARHL is not well understood. 
However, new promising technology and strategies may help to discover the exact role of 
genetic mutations in presbycusis. Finding of the genetic variants causing ARHL will 
ultimately lead to discovery of new pharmaceutical interventions and the development of 
new approaches to identify at risk individuals.  
 
 Protein or Function Gene SNP (RS number) 
Van Eyken et 
al., 2006 
Potassium channel (voltage-gated) KCNQ4 SNP9 (rs727146) 
SNP12 (rs2149034) 
SNP18 (rs12143503) 
Unal et al., 
2005 
metabolism of cytotoxic, 
carcinogenic compounds and ROS 
N-
acetyltransfer
ase 2 
NAT2*6A (rs1799930) 
Van Laer et 
al., 2008 
transcription factor cellular 
promoter 2-like 3 
GRHL2 36738A>G (rs10955255) 
42731C>T (rs2127034) 
53110C>T (rs1981361) 
Friedman et 
al., 2009 
glutamate receptor, metabotropic,7GRM7 7155702T>A (rs11928865)
Van Laer et 
al., 2010 
IQ motif-containing GTPase-
activating-like protein 
IQGAP2 75920972A>G (rs457717)
75922504C>T (rs1697845)
Table 5. SNPs associated with ARHL. 
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6. Syndromic genetic deafness 
More than 400 syndromes have been described in OMIM. Here, genetic aspects of common 
syndromes which are associted with HL are briefly explained.  
Usher Syndrome: Usher syndrome, named after Charles Usher (1914) a British 
ophthalmologist, is the most prevalent cause of autosomal recessive HL, accounting for 
nearly 3-5 per 100,000 in the general population and 1-10% among profoundly deaf children 
[Boughman et al., 1983].  Several clinical subtypes have been distinguished based on its 
characterized features i. e. severity of the HL and the onset of retinitis pigmentosa [Yan & 
Liu, 2010].  Type 1 patients have profound HL, vestibular dysfunction and the onset of 
retinitis pigmentosa in childhood [Hope et al., 1997]. The type 2 patients have normal 
vestibular response, mild to moderate HL and RP begins in the second decade of life [Hope 
et al., 1997]. Progressive HL and variable vestibular response characterize type 3 patients 
and the onset of retinitis pigmentosa is variable as well [Smith et al., 1995]. Usher syndrome 
has a heterogeneous causality (Table 6); to date, 12 different loci and 10 genes have been 
reported (http://hereditaryhearingloss.org/). One of these identified genes, MYO7A, 
encoding myosin 7A, is a unique molecular motor for hair cells [Weil et al., 1995].  Cadherin 
23, an adhesion molecule, coded by CDH23 gene may have an important role in crosslinking 
of stereocilia [Bolz et al., 2001; Bork et al., 2001].   
 
Locus Gene Ref. 
USH1B (11q13.5) MYO7A Weil et al.,1995 
USH1C (11p15.1) USH1C Smith et al., 1992  
USH1D (10q22.1) CDH23 Bork et al., 2001  
USH1F (10q21-22) PCDH15 Ahmed et al., 2001  
USH1G (17q24-25) SANS Mustapha et al., 2002  
USH2A (1q41) USH2A Kimberling et al., 1990  
USH2C (5q14.3-q21.3) VLGR1 Weston et al., 2004  
USH2D (9q32) WHRN Ebermann et al., 2007 
USH3 (3q21-q25) USH3A Joensuu et al., 2001  
10q24.31 PDZD7 Ebermann et al., 2010 
Table 6. Reported genes for Usher syndrome. 
Pendred syndrome: Pendred syndrome, named after Vaughan Pendred (1896) a British 
physician, is the most common syndromic form of HL and associated with abnormal iodine 
metabolism (goiter).  It is an autosomal recessive disorder which accounts for 4-10% of deaf 
cases [Fraser 1965]. The defective organic binding of iodine in the thyroid gland may 
distinguished by a positive potassium perchlorate discharge test; however the test is not 
specific and its sensitivity is unclear.  HL is usually bilateral, severe to profound and may be 
present at birth, and sloping in the higher frequencies [Kopp et al., 2008]. The casual gene is 
SLC26A4 (PDS) on chromosome 7q31 encoding a protein named pendrin (Figure 3). It 
regulates transportation of iodine and chloride/ bicarbonate ions in the inner ear, thyroid, 
and kidney.  Mutations of this gene can cause NSHL DFNB4 and enlarged vestibular 
aqueduct syndrome as well [Everett et al., 1997]. 
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Fig. 3. Hypothetic structure and domains of Pendrin protein. The most common mutations 
(L236P, IVS8+1G>A, T416P, and H723R) accounting for approximately 60% of the total PS 
genetic load are shown. TM1-TM12 denotes transmembrane domains, EC1-6 denotes 
extracellular domains, IC denotes cytoplasmic domain, NT denotes amino (NH2) terminus 
and CT denotes carboxyl (COOH) terminus. 
Alport syndrome: Alport syndrome, a hereditary disorder of basement membranes, is 
characterized by renal abnormalities including glomerulonephritis, hematuria (“red 
diaper”) and renal failure, and ocular problems as well as progressive sensorineural HL 
[Wester et al., 1995]. Mutations in various genes encoding type 4 collagen (COL4A3, 
COL4A4 and COL4A5) have been reported to cause Alport syndrome [Lemmink et al., 1994; 
Hudson et al., 2003]; nearly 85% of the cases are due to COL4A5 mutations [Hudson et al., 
2003].  These collagens are components of the basilar membranes, the spiral ligament and 
stria vascularis. X-linked pattern of inheritance is observed in the majority (80 %); the 
remaining shows autosomal recessive [Lemmink et al., 1994] and autosomal dominant [van 
der Loop et al., 2000], inheritance patterns. It is estimated that 10% to 15% of X-linked 
patients represent de novo mutations in COL4A5 [Gubler et al., 2007]. Since uremia leads 
to death in males prior to 30 years of age, it is essential to diagnose it early in men. 
Symptoms are usually more severe than women. The progressive sensorineural HL 
usually begins in the adolescent years [Wester et al., 1995]. The mechanism of HL has not 
been explained exactly yet, although the basement membrane damages are suggested to 
affect adhesion of the cells of the organ of Corti and basilar membrane leading to HL 
[Merchant et al., 2004]. 
Waardenburg syndrome: Waardenburg disease, named after Petrus Johannes Waardenburg 
(1886-1979), accounts for 1-3% of congenital HL [Read & Newton, 1997].  In addition, the 
disease shows other clinical features. Four types of syndrome can be distinguished on the 
basis of accompanying abnormalities [Read & Newton, 1997]: In type 1, patients show 
dystopia canthorum, iris heterochromy, brilliant blue eyes, broad nasal root, premature 
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graying of hair, white forelock, and vestibular dysfunction. Type 2 patients have similar 
phenotype but not dystopia canthorum. In type 3 (so called Klein-Waardenburg syndrome) 
[Klein, 1983], upper extremity abnormalities other Type 1 clinical features and dystopia 
canthorum and are observed.  In type 4 (so called Shah-Waardenburg syndrome) [Shah et 
al., 1981] patients demonstrate all findings shown in Type 2 with the addition of 
pigmentation abnormalities and Hirschsprung’s disease.  Sensorineural hearing loss is 
observed in 60 % and 90 % of type 1 and type 2 patients, respectively [Newton, 1990].  
Types 1 and 3 of Waardenburg syndrome occur due to mutations in the PAX3 gene 
encoding a DNA-binding protein essential for determining the fate of neural crest cells 
[Baldwin et al., 1994]. Type 2 is due to mutations in MITF gene [Tassabehji et al., 1994]. 
Mutations in three genes, EDN3, SOX10 and EDNRB genes, can lead to Type 4 [Edery et al., 
1996; Hofstra et al., 1996; Pingault et al., 1998].  SOX10 mutations, account for approximately 
half of type 4 patients and are likely responsible for about 15% of Type 2 as well [Bondurand 
et al., 2007]. In vitro studies have shown that EDN3 plays as a stimulation factor of 
proliferation and melanogenesis of neural crest cells.  EDNRB is suggested to have an 
important role in the development of epidermal melanocytes and enteric neurons.  SOX10 is 
a DNA-binding transcription factor and involved in promoting cell survival prior to lineage 
commitment [Kapur, 1999].  There is a wide range of variation in HL phenotype so that 
some patients may not exhibit HL.  
Branchio-oto-renal syndrome: Branchio-oto-renal syndrome (BOR) is an autosomal 
dominant disorder, accounting for 2% of profoundly deaf children and is characterized by 
branchial derived anomalies, otologic anomalies (Mondini’s dysplasia and stapes fixation) 
and renal malformation.  HL may affect 70-93% of the BOR patients but there is a high 
variability in age of onset and severity [Chen et al., 1995].  HL can be sensorineural, 
conductive or mixed, stable or progressive and mild or profound.  Mutations in EYA1 gene 
have been identified to cause BOR syndrome (BOR1) [Abdelhak et al., 1997].  It has been 
shown that this gene has a role in development of the inner ear and kidney [Abdelhak et al., 
1997].  Studies of transgenic mice have indicated that EYA1 homozygous knockouts have 
not developed ears and kidneys. In addition to EYA1, mutations in two genes named SIX1 
and SIX5 have been reported to cause BOR3 and BOR2, respectively [Ruf et al., 2004; 
Hoskins et al., 2007].  
Stickler Syndrome: Stickler Syndrome (STL), named after Stickler (1965), follows an 
autosomal dominant pattern of inheritance and is characterized by progressive 
sensorineural HL, cleft palate, abnormal development of the epiphysis, vertebral 
abnormalities and osteoarthritis. On the basis of clinical features, four types of STL exist.  
Type 1 patients have typical features of the disease including progressive myopia leading to 
retinal detachment, midface hypoplasia, cleft palate, variable sensorineural HL and 
vitreoretinal degeneration.  Mutations in COL2A1 gene encoding a fibrillar collage type 2 
subunitA1 can cause the classic phenotype [Ahmad et al., 1991]. There is no retinal 
detachment in Type 2 andthe phenotype is caused by COL11A1 gene mutations [Richards 
et al., 1996]. Facial abnormalities seen in Type 1 are not observed in Type 3. Mutations of 
COL11A2 lead to STL Type 3 [Vikkula et al., 1995]. Recently, mutations in COL9A1 have 
been identified to cause an autosomal recessive form of STL, Type 4 [Van Camp et al., 
2006]. 
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7. Genetic evaluation 
The main problem in the diagnosis of disorders such as deafness is its heterogenicity.  
Genetic study of HL has considerable benefits for patients which are as follows: 
a. Identifying the medical and non medical decisions e.g cochlear implant  
b. Carrier testing and prenatal diagnosis 
c. Prediction for the progressive state of the disease 
d. Eliminating unnecessary tests and investigations 
e. Providing appropriate genetic counseling before marriage, especially when they have 
heterogeneous conditions that carry different mutated genes. 
Genetic evaluation should be considered for children with newly diagnosed loss of hearing 
especially if no specific cause is determined.  For example, there is no need for genetic 
evaluation of the family of a child with HL due to meningitis; although, they may need 
assurance of not transmitting the disease to the next generation.  Genetic evaluation includes 
several steps: 
1. Reviewing the complete history of prenatal, neonatal and medical history of growth and 
development  
2. Complete physical examination of patients and other family members 
3. Evaluating the genetics, molecular and cellular diagnosis 
Based on previous studies, deaf people have positive assortive marriage; it is estimated that 
90% of deaf individuals marry deaf.  Depending on the pattern of inheritance they might 
have a deaf child.  For example if both parental recessive alleles are similar, there is 100% 
chance of having a deaf child; and if one of the parents carry a dominant form of HL and the 
other carry the recessive form of HL the chance would be 50% for the dominant gene. 
Early diagnosis of HL is important in gaining speech progression and social skills of the 
children which would lead to better life of these individuals and would later help them in 
cochlea implant.  Hereditary or genetic understanding of the causes of HL is important.  The 
benefits of this understanding and knowledge, not only allows physicians to help the 
families of at risk but also may help in treatment and control of HL.  Sometimes it is possible 
to prevent hearing loss from worsening.  HL may be one of the clinical signs of a syndrome 
and if the genetic cause of HL is determined it may help to predict and treat other clinical 
complications [Extivill et al., 1998]. 
8. Conclusion 
HL is the most common sensory defect affecting human beings. It is categorized on the basis 
of several criteria. Genetic factors can be traced in half of the cases. Nonsyndromic HL can 
follow any of the Mendelian inheritance patterns, but the majority are ARNSHL. 
Approximately fifty genes have been reported to be involved in HL, and based on an 
estimation nearly 200 to 250 genes may cause HL. Genetic understanding of the causes of 
HL and finding the molecular mechanism of hearing process are valuable for genetic 
counseling, prevention and development of new therapeutic approaches. Many studies have 
been published about finding  new genes causing prelingual nonsyndromic HL. Presbycusis 
is very common among eldely people and research on this phenotype needs more attention. 
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New technology and strategies such as next generation sequencing can help to discover new 
genes for deafness in future. 
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